Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
PZ HTL SA
GLOBETECH PUBLISHING

UK Government Initiates Competition to Map Rare Cancer Genes

By BiotechDaily International staff writers
Posted on 17 Dec 2013
A GBP 10 million competition has been established to help biotech companies develop advanced technology to map and analyze genes.

Companies that win the competition will be funded to develop high-tech products to help identify and treat inherited diseases and cancer. Concepts could include new computer code or hardware, or enhancement of existing software and technology. 

The competition will run together with plans to map the DNA code of up to 100,000 UK National Health Service (NHS) patients with cancer and rare diseases by 2017. The products developed as part of the competition will play a part in reaching this goal. Public Health England (London, UK) is also leading work to use whole genome sequencing to treat infectious diseases.

UK Heath Minister Lord Howe said, “Our plans to map 100,000 genomes over the next five years will lead to truly ground-breaking discoveries about how diseases work and how we can treat them more effectively. This competition helps harness the creativity and ingenuity of businesses to help us reach our target. Our investment in pioneering scientific research is good news for patients, for the research sector and for the economy, creating jobs and growth in our world-beating life sciences industry, and helping the UK compete in the global race.”

The competition is part of the Government’s commitment to making the United Kingdom one of the best places to start and grow a business. Application forms and additional details about this competition can be found online (please see Related Links below). The deadline for entries is February 5, 2014. Winning proposals will be announced in March 2014.

The UK Department of Health (DH; London, UK) is funding the competition through the Small Business Research Initiative (SBRI). 

Related Links:

Public Health England
UK Department of Health
Technology Strategy Board

 


Channels

Genomics/Proteomics

view channel
Image: The TheraCyte cell encapsulation device (Photo courtesy of TheraCyte, Inc.).

Encapsulated Human-Insulin-Producing Progenitor Cells Cure Diabetes in Mouse Model

A breakthrough system that allows subcutaneous implantation of encapsulated immature pancreatic cells (beta progenitor cells) was shown to produce enough insulin to correct the symptoms of diabetes in a mouse model.... Read more

Drug Discovery

view channel
Image: Chitosan is derived from the shells of shrimp and other sea crustaceans, including Alaskan pink shrimp, pictured here (Photo courtesy of NOAA - [US] National Oceanic and Atmospheric Administration).

Chitosan Treatment Clears the Way for Antibiotics to Eliminate Recurrent Urinary Tract Infections

Recurrent urinary tract infection was successfully resolved in a mouse model by treatment with the exfoliant chitosan followed by a round of antibiotics. Bacterial urinary tract infection (UTI), most... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.